Teva Pharmaceutical acquires Theramex - MarketLine Financial Deals

Teva Pharmaceutical acquires Theramex

Teva Pharmaceutical acquires Theramex - MarketLine Financial Deals
Teva Pharmaceutical acquires Theramex
Published Jan 05, 2011
3 pages — Published Jan 05, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Teva Pharmaceutical Industries, Ltd., an Israel-based pharmaceutical company, has acquired Theramex SpA, a Monaco-based developer of women's healthcare products, from Merck Serono S.A.

  
Source:
Document ID
MA36477_101101
Country
Country
Country
Country
Ticker
MRCG=DE
Ticker
SRA=CH
Ticker
TEVA=IL
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Teva Pharmaceutical acquires Theramex" Jan 05, 2011. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Teva-Pharmaceutical-acquires-Theramex-2052-46211>
  
APA:
MarketLine Financial Deals. (2011). Teva Pharmaceutical acquires Theramex Jan 05, 2011. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Teva-Pharmaceutical-acquires-Theramex-2052-46211>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.